Use of Gefitinib in EGFR-Amplified Refractory Solid Tumors: An Open-Label, Single-Arm, Single-Center Prospective Pilot Study.
Seonggyu ByeonJung Yong HongJeeyun LeeDo-Hyun NamSe Hoon ParkJoon Oh ParkYoung Suk ParkHo Yeong LimWon Ki KangSeung Tae KimPublished in: Targeted oncology (2020)
NCT02447419.